Abstract
Li‐Fraumeni syndrome (LFS) is a rare, autosomal dominant inherited cancer predisposition syndrome associated with germline mutation of the TP53 tumor suppressor gene [1, 2]. It is traditionally characterized by early‐onset of multiple primary tumors: sarcoma, breast cancer, brain tumor, leukemia, and adrenocortical carcinoma. [2] Classically, LFS is clinically diagnosed when a patient present with sarcoma diagnosed before age 45 years with a first‐degree relative with any cancer before age 45 years and an additional first‐ or second‐degree relative with any cancer before age 45 years or a sarcoma at any age.
This article is protected by copyright. All rights reserved.
http://bit.ly/2W0Xdc3
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου